Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)
Mission: A collaborative partnership between UMB and UMCP focused on modernizing and improving the ways drugs and medical devices are reviewed and evaluated.
To learn more
About
M-CERSI is a collaborative partnership between UMB and UMCP, funded by the U.S. Food and Drug Administration (FDA). The center unites researchers from both campuses with FDA scientists to develop new tools, standards, and approaches for assessing FDA-regulated products.
M-CERSI also offers a Master of Science in Regulatory Science, providing advanced training for professionals in drug and device regulation.
M-CERSI, the nation’s oldest and one of only five FDA-funded CERSIs nationwide, continues to lead innovation in regulatory science, benefiting patients and strengthening Maryland’s life sciences ecosystem.
M-CERSI in the News
- Jim Polli Appointed as MPower Professor
- FDA Agreement Provides $50 Million for Regulatory Science
- M-CERSI and FDA’s AI workshop highlighting future FDA comment period on AI in drug development
